Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 24% ± 5% | |
astrocyte | 4 studies | 26% ± 7% | |
GABAergic neuron | 3 studies | 26% ± 6% | |
glutamatergic neuron | 3 studies | 32% ± 8% | |
dendritic cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2542.40 | 1445 / 1445 | 100% | 16.67 | 183 / 183 |
ovary | 100% | 2748.91 | 180 / 180 | 100% | 24.18 | 430 / 430 |
prostate | 100% | 3563.25 | 245 / 245 | 100% | 19.56 | 502 / 502 |
skin | 100% | 2463.70 | 1809 / 1809 | 100% | 24.34 | 472 / 472 |
stomach | 100% | 2346.28 | 359 / 359 | 100% | 18.58 | 286 / 286 |
thymus | 100% | 3122.19 | 653 / 653 | 100% | 22.86 | 605 / 605 |
uterus | 100% | 3520.84 | 170 / 170 | 100% | 23.98 | 459 / 459 |
brain | 100% | 2130.71 | 2640 / 2642 | 100% | 24.23 | 705 / 705 |
lung | 100% | 2283.55 | 578 / 578 | 100% | 21.12 | 1152 / 1155 |
intestine | 100% | 2794.14 | 966 / 966 | 100% | 20.67 | 525 / 527 |
bladder | 100% | 2869.29 | 21 / 21 | 100% | 20.03 | 502 / 504 |
breast | 100% | 2413.01 | 459 / 459 | 100% | 21.91 | 1113 / 1118 |
kidney | 100% | 2306.87 | 89 / 89 | 99% | 14.53 | 891 / 901 |
pancreas | 99% | 1349.38 | 326 / 328 | 99% | 19.28 | 176 / 178 |
adrenal gland | 100% | 3119.04 | 258 / 258 | 98% | 17.45 | 225 / 230 |
liver | 100% | 1580.08 | 226 / 226 | 98% | 12.60 | 397 / 406 |
adipose | 100% | 2072.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 15.29 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.12 | 29 / 29 |
spleen | 100% | 3930.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.24 | 1 / 1 |
blood vessel | 100% | 2459.46 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1288.71 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1329.24 | 855 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 1386.15 | 848 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000434 | Biological process | regulation of protein neddylation |
GO_0000338 | Biological process | protein deneddylation |
GO_0010387 | Biological process | COP9 signalosome assembly |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | COPS7B |
Protein name | COP9 signalosome subunit 7B COP9 signalosome complex subunit 7b (SGN7b) (Signalosome subunit 7b) (JAB1-containing signalosome subunit 7b) |
Synonyms | CSN7B |
Description | FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . |
Accessions | ENST00000449784.5 J3QT50 ENST00000450501.5 ENST00000412922.6 ENST00000373608.7 [Q9H9Q2-3] J3QT95 ENST00000432387.5 ENST00000620578.4 [Q9H9Q2-2] J3KQV6 ENST00000412591.5 J3KQ34 J3QT73 J3KQ41 ENST00000631349.1 Q9H9Q2 J3QT43 ENST00000409091.5 [Q9H9Q2-2] ENST00000410024.5 [Q9H9Q2-1] ENST00000436564.5 J3QT67 J3QT66 ENST00000410017.5 ENST00000413197.5 A0A087X1P5 ENST00000357490.6 ENST00000350033.8 [Q9H9Q2-1] ENST00000409295.5 ENST00000611614.4 J3QT65 ENST00000449174.1 |